Onconova Therapeutics Priced, Nasdaq: ONTX
Biotech focused on developing drug candidates for cancer and related diseases.
Industry: Health Care
First Day Return: +32.5%
ONTX
Biotech focused on developing drug candidates for cancer and related diseases.
| IPO Data | |
|---|---|
| IPO Date | 07/24/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $78 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Newtown, PA, United States |
| Founded | 1998 |
| Employees at IPO | 56 |
| Website www.onconova.com | |
IPO News for Onconova Therapeutics
Onconova Therapeutics (ONTX) Performance
